Target Audience:

• HBS 
• Primary Care 
• Sub Specialists 

Links:

Lunch RSVP (By TBD): 

WebEx (Please MUTE yourself upon entry): 

Post Presentation Survey (By TBD) : Available after event

Speakers:

• Dr. Samineh Medina, Edocrinology Kaiser San Jose

Planners:

• Rizwana Chaudhry

Session Objectives:

At the conclusion of this event, participants will be able to: 

1. Identify DKA patients who can be managed on the non ICU floors.
2. Apply new protocol for the management of DKA patients with mild to moderateacidosis

Content:

Diabetic ketoacidosis DKA is a common condition which is entertained in theemergency room and hospital. Recently management of DKA has gone throughnumber of changes which require review of DKA management. Patients with DKAused to be managed on insulin drip in the ICU intensive care unit setting but recentstudies have proved safe management of these patients on the non ICU floors onsubcutaneous insulin administration. This event will clarify the patient populationswhere subcutaneous insulin administration is the correct treatment for themanagement of DKA. Our hospital also up dated recently the DKA managementalgorithm, speaker will also address the changes in the new protocol.

Disclosure:

The speaker and planning committee have no financial relationships to disclose. 

Resources:

4.6.17_Diabetic Ketoacidosis_PPT.pdf

Credit Statement:

**Kaiser Permanente San Jose Medical Center is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.   
Kaiser Permanente San Jose takes responsibility for the content, quality and scientific integrity of this CME activity.                
**Kaiser Permanente San Jose Medical Center designates this Live Course for a maximum of 1.0 AMA PRA Category 1 Credit™        
Physicians should claim only the credit commensurate with the extent of their participation in the activity.